EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance

Rima Rachid iD, Monica Martinez-Blanco iD, Gavin A Kuziel iD, Emmanuel Stephen-Victor iD, Mathieu Groussin iD, Askarbek Orakov iD, George Russell, Le Thanh Tu Nguyen iD, Mathilde Poyet iD, Zhussipbek Mukhatayev, Christina S K Yee iD, Sultan Albuhairi und 24 weitere

Science Translational Medicine · 05.08.2026 · 18 (861)

DOI: 10.1126/scitranslmed.aee3263 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Science Translational Medicine, erschienen am 05.08.2026. Verfasst von Rima Rachid und 35 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Bile Acids and Salts, Food Hypersensitivity, Fecal Microbiota Transplantation, Immune Tolerance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome has been implicated in the pathogenesis of food allergy (FA), prompting microbiome-focused interventions. We evaluated, in a phase 1 open-label trial (NCT02960074), the safety and efficacy of oral encapsulated fecal microbiome transplantation (FMT) in 15 adults with peanut allergies. An increase in the peanut reactivity threshold was noted in 3 of 10 participants not pretreated with antibiotics and 3 of 5 participants pretreated with antibiotics, without safety issues. In responders, FMT increased tolerogenic RORγt + regulatory T cells (T reg cells) and decreased T helper 2 cells (T H 2 cells). Mice transplanted with the microbiomes of post-FMT responders were protected from FA in association with increased RORγt + T reg cell percentages and increased colonization with members of the gut Bacteroides . In both humans and mice, protection by FMT was associated with increased bile acid metabolites. Deletion of a bile salt hydrolase in a candidate protective Bacteroides abrogated FA suppression in mice. These results suggest that FMT is a safe and potentially promising therapeutic modality for treating FA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Acids and SaltsFood HypersensitivityFecal Microbiota TransplantationImmune ToleranceAnimalsHumansMiceAdultT-Lymphocytes, RegulatoryAdministration, OralFemaleMale

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Division of Immunology, Boston Children's Hospital, Boston, MA, USA.
  • Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Division of Infectious Diseases and Division of Gastroenterology, Boston Children's Hospital, Boston, MA, USA.
  • Department of Microbiology, Harvard Medical School, Boston, MA, USA.
  • Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.

ORCID-Profile: Rima Rachid, Monica Martinez-Blanco, Gavin A Kuziel, Emmanuel Stephen-Victor, Mathieu Groussin, Askarbek Orakov, Le Thanh Tu Nguyen, Mathilde Poyet, Christina S K Yee, Ziwei Wang, Suzanne Dahlberg, Morgan Ryan, Meghan Fitzgerald, Lynda Schneider, Elena Crestani, Elizabeth Burke-Roberts, Ryan J Elliott, Robert Voyksner, Curtis Huttenhower, Eric Alm, Talal A Chatila

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Rachid, R., Martinez-Blanco, M., Kuziel, G. A., Stephen-Victor, E., Groussin, M., Orakov, A., Russell, G., Nguyen, L. T. T., Poyet, M., Mukhatayev, Z., Yee, C. S. K., Albuhairi, S., Kteish, R., Rahman, E. A., Farraj, F. A., Wang, Z., Dahlberg, S., Ryan, M., Fitzgerald, M., …, & Chatila, T. A. (2026). Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance. Science Translational Medicine, 18(861). https://doi.org/10.1126/scitranslmed.aee3263

Vancouver

Rachid R, Martinez-Blanco M, Kuziel GA, Stephen-Victor E, Groussin M, Orakov A, et al. Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance. Science Translational Medicine. 2026;18(861). doi:10.1126/scitranslmed.aee3263

BibTeX
@article{Rachid2026,
  author = {Rachid, Rima and Martinez-Blanco, Monica and Kuziel, Gavin A and Stephen-Victor, Emmanuel and Groussin, Mathieu and Orakov, Askarbek and Russell, George and Nguyen, Le Thanh Tu and Poyet, Mathilde and Mukhatayev, Zhussipbek and Yee, Christina S K and Albuhairi, Sultan and Kteish, Rayan and Rahman, Ebla Abdel and Farraj, Farida Abi and Wang, Ziwei and Dahlberg, Suzanne and Ryan, Morgan and Fitzgerald, Meghan and Elverson, Wendy and Lee, John J and Schneider, Lynda and MacGinnitie, Andrew and Crestani, Elena and Queheillalt, Dianna and Burke-Roberts, Elizabeth and Watson, Jonathan and Elliott, Ryan J and Wong, Wing Fei and Osman, Majdi and Voyksner, Robert and Hohmann, Elizabeth and Huttenhower, Curtis and Alm, Eric and Rakoff-Nahoum, Seth and Chatila, Talal A},
  title = {Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {861},
  doi = {10.1126/scitranslmed.aee3263}
}
Kostenlos starten →